Silvana Soto-Rodriguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Silvana Soto-Rodriguez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Mari Carmen Gomez-Cabrera
University of Valencia
4 shared publications - Gloria Olaso-Gonzalez
Departamento de Fisiología, Universitat de València
3 shared publications - Abril Gorgori-Gonzalez
Freshage Research Group, Department of Physiology, Faculty of Medicine, University of Valencia, Fundacion Investigacion Hospital Clinico Universitario/INCLIVA, Valencia, Spain; CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES) ISCIII, Madrid, Spain
2 shared publications - Balma Boira-Nacher
Department of Physiology, Faculty of Medicine University of Granada Granada Spain
2 shared publications - Cristian Martínez Fajardo
Instituto Botánico, Departamento de Ciencia y Tecnología Agroforestal y Genética, Universidad de Castilla-La Mancha, Campus Universitario s/n, 02071 Albacete, Spain
2 shared publications - Erika Ria Ulrika Kajander
Department of Physiology, Faculty of Medicine, University of Valencia and CIBERFES, Fundación Investigación Hospital Clínico Universitario/INCLIVA, 46010 Valencia, Spain
2 shared publications
Latest Publications
- Open Access
- 15 October 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 257, 608-615
Redox resilience in skeletal muscle aging: cellular adaptations and exercise-mediated homeostasis
- 15 October 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 257, 608-615
Open AccessRedox resilience in skeletal muscle aging: cellular adaptations and exercise-mediated homeostasis
- Top Cited PapersOpen Access
- 1 January 2026
- Published by KEAI Publishing in Sports Medicine and Health Science
- Vol. 8 (1) , 23-33
Leveraging mitochondrial stress to improve healthy aging
Aging is characterized by a progressive decline in physiological function, driven by intrinsic mechanisms (primary aging) and modifiable factors (secondary aging), ultimately leading to multimorbidity, disability, and mortality. Mitochondrial dysfunction, a major hallmark of aging, plays a central role in the loss of muscle mass and strength observed in frailty and sarcopenia. With age, mitochondrial quality control processes, including biogenesis, mitophagy, and dynamics, become dysregulated, impairing energy metabolism and muscle homeostasis.
- 1 January 2026
- Published by KEAI Publishing in Sports Medicine and Health Science
- Vol. 8 (1) , 23-33
Top Cited PapersOpen AccessLeveraging mitochondrial stress to improve healthy aging
Aging is characterized by a progressive decline in physiological function, driven by intrinsic mechanisms (primary aging) and modifiable factors (secondary aging), ultimately leading to multimorbidity, disability, and mortality. Mitochondrial dysfunction, a major hallmark of aging, plays a central role in the loss of muscle mass and strength observed in frailty and sarcopenia. With age, mitochondrial quality control processes, including biogenesis, mitophagy, and dynamics, become dysregulated, impairing energy metabolism and muscle homeostasis.
- Open Access
- 16 December 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (12) , 1697
Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds
Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.
- 16 December 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (12) , 1697
Open AccessOsteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds
Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.
- Open Access
- 29 November 2024
- Published by MDPI AG in Preprints.org
Osteoporosis: Causes, Mechanisms, Treatment and Prevention. Role of Dietary Compounds
Osteoporosis is a chronic disease that is characterized by a loss of bone density, mainly affecting the microstructure of the bones, due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review we discuss causes, biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and effects of diet, focusing in this case on compounds present in the diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as concluding remarks that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.
- 29 November 2024
- Published by MDPI AG in Preprints.org
Open AccessOsteoporosis: Causes, Mechanisms, Treatment and Prevention. Role of Dietary Compounds
Osteoporosis is a chronic disease that is characterized by a loss of bone density, mainly affecting the microstructure of the bones, due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review we discuss causes, biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and effects of diet, focusing in this case on compounds present in the diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as concluding remarks that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.